American Type Culture Collection Vero Cells Used To Manufacture Second Rotavirus Vaccine For Clinical Trials

Published: Nov 20, 2007

MANASSAS, Va.--(BUSINESS WIRE)--ATCC (American Type Culture Collection) announced today that its master cell bank of highly characterized Vero cells will be used for the manufacture of a second promising rotavirus vaccine candidate. The rotavirus vaccine candidate was developed by Murdoch Childrens Research Institute (MCRI) in Victoria, Australia. ATCC Vero cells will be used as substrates to grow the rotavirus strain that is being used in the vaccine.

Back to news